Printer Friendly
The Free Library
14,709,470 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Protein vaccine slows leukemia. (Cancer).


By injecting leukemia patients with part of a protein found in greater abundance on cancerous cells than on healthy ones, researchers have been able to induce some patients' immune systems to fight this blood cancer.

Jeffrey J. Molldrem of the University of Texas M.D. Anderson Cancer Center in Houston and his colleagues fashioned the cancer vaccine The term cancer vaccine is often used to describe a process whereby a person's immune system is coaxed into recognizing and destroying malignant cells without harming normal cells.  from a piece of proteinase proteinase /pro·tein·ase/ (pro´ten-as?) endopeptidase.

pro·tein·ase
n.
A protease that begins the hydrolytic breakdown of proteins usually by splitting them into polypeptide chains.
 3, a compound overproduced by malignant blood cells blood cells,
n.pl the formed elements of the blood, including red cells (erythrocytes), white cells (leukocytes), and platelets (thrombocytes).


blood cells

See erythrocyte and leukocyte. Platelets are classed separately.
 in leukemia patients. Earlier research suggested that the piece, called PRI PRI: see Institutional Revolutionary party.


(Primary Rate Interface) An ISDN service that provides 23 64 Kbps B (Bearer) channels and one 64 Kbps D (Data) channel (23B+D), which is equivalent to the 24 channels of a T1 line.
, stimulates production of immune system T cells T cells
A type of white blood cell produced in the thymus gland. T cells are an important part of the immune system. Infants born with an underdeveloped or absent thymus do not have a normal level of T cells in their blood.
 that specifically target proteinase 3.

Molldrem's group identified 15 patients with leukemia that had resisted other treatment. Each patient received three PRI injections, each separated by 3 weeks. In five people, the leukemia went into remission and their T cells showed a strong attraction to the leukemia cells. Three other patients in the group showed partial responses.

Molldrem and his colleagues are now testing the vaccine in 60 more leukemia patients.--N.S.
COPYRIGHT 2003 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Science News
Article Type:Brief Article
Geographic Code:1USA
Date:Jan 4, 2003
Words:161
Previous Article:Hawaii's hated frogs: tiny invaders raise a big ruckus.(populations of coquies, frogs native to Puerto Rico, invade Hawaii)(Cover Story)
Next Article:Getting the iron out. (Anemia).(getting rid of excess iron in the body)
Topics:



Related Articles
Vaccine for cats' number one killer. (feline leukemia)
The AIDS virus: equine similarities?
Renegade tumors. (relation of protein to cancers)
One-two drug punch trips up leukemia.(Brief Article)
Immune cells target cancerous tissue. (Vaccine Power).(prostate cancer vaccine)(Brief Article)
Cancer vaccine gets first test in patients. (Immunology).(Brief Article)
Tiny bubbles: vesicles that cells spit out are implicated in cancer and AIDS.
Biotechnology and drug discovery: from bench to bedside.(Original Article)
Biomedicine.(Science News Of the year)
Mother's pre-pregnancy diet may influence child cancer risk.(Maternal Nutrition and Child Cancer)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles